Pharmabiz

Lenacapavir approved in Zambia and Zimbabwe in record time through WHO Collaborative Registration Procedure

Lenacapavir approved in Zambia and Zimbabwe in record time through WHO Collaborative Registration Procedure: Geneva Wednesday, December 3, 2025, 17:00 Hrs [IST] The Zambia Medicin ...
Pharmabiz

Citius Oncology launches US FDA approved Lymphir, a novel cancer immunotherapy for cutaneous T-cell lymphoma

Citius Oncology launches US FDA approved Lymphir, a novel cancer immunotherapy for cutaneous T-cell lymphoma: Cranford, New Jersey Wednesday, December 3, 2025, 16:00 Hrs [IST] Cit ...
Pharmabiz

Bayer initiates phase III study SUNFLOWER with long-acting reversible intrauterine system for treatment of nonatypical endometrial hyperplasia

Bayer initiates phase III study SUNFLOWER with long-acting reversible intrauterine system for treatment of nonatypical endometrial hyperplasia: Berlin Wednesday, December 3, 2025, ...
Pharmabiz

GSK to present new data from its haematology portfolio at the 67th ASH Annual Meeting and Exposition

GSK plc will present new data from its haematology portfolio at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition (6 - 9 December), reinforcing its potential to redefine ...
Pharmabiz

WHO issues global guideline on the use of GLP-1 medicines in treating obesity

WHO issues global guideline on the use of GLP-1 medicines in treating obesity: Geneva Wednesday, December 3, 2025, 14:00 Hrs [IST] To address the growing global health challenge o ...
Pharmabiz

Roche gets US FDA clearance with CLIA waiver and CE Mark for its first point-of-care test for diagnosing Bordetella infections, including whooping cough

Roche gets US FDA clearance with CLIA waiver and CE Mark for its first point-of-care test for diagnosing Bordetella infections, including whooping cough: Basel Wednesday, December ...
Pharmabiz

Kiora Pharma receives US patent covering additional formulations for the KIO-100 family of anti-inflammatory compounds

Kiora Pharma receives US patent covering additional formulations for the KIO-100 family of anti-inflammatory compounds: Encinitas, California Wednesday, December 3, 2025, 11:00 Hr ...
Pharmabiz

WuXi Biologics extends global CRDMO network to Qatar through strategic MoU signed with Qatar Free Zones Authority

WuXi Biologics extends global CRDMO network to Qatar through strategic MoU signed with Qatar Free Zones Authority: Doha Wednesday, December 3, 2025, 12:00 Hrs [IST] WuXi Biologics ...
Opinion
PharmabizOpinion

Pharma quality issues - need prevention-driven regulatory culture

Pharma quality issues - need prevention-driven regulatory culture: Dr. M. Aamir Mirza Wednesday, December 3, 2025, 08:00 Hrs [IST] The concerns surrounding the quality of pharmace ...
Pharmabiz

AstraZeneca’s NDA for baxdrostat accepted under US FDA Priority Review in US for patients with hard-to-control hypertension

AstraZeneca’s NDA for baxdrostat accepted under US FDA Priority Review in US for patients with hard-to-control hypertension: Cambridge, UK Wednesday, December 3, 2025, 09:00 Hrs ...
Pharmabiz

Exporters to strengthen supply chain independence as MSMEs struggle to meet revised Schedule M deadline

Exporters to strengthen supply chain independence as MSMEs struggle to meet revised Schedule M deadline: Shardul Nautiyal, Mumbai Wednesday, December 3, 2025, 08:00 Hrs [IST] Even ...
Pharmabiz

Exporters report gradual recovery amidst depreciation of local currencies in Africa

Exporters report gradual recovery amidst depreciation of local currencies in Africa: Shardul Nautiyal, Mumbai Wednesday, December 3, 2025, 08:00 Hrs [IST] Despite lingering cash f ...